首页> 外文OA文献 >Relationship between prognostic score and thyrotropin receptor (TSH-R) in papillary thyroid carcinoma: immunohistochemical detection of TSH-R.
【2h】

Relationship between prognostic score and thyrotropin receptor (TSH-R) in papillary thyroid carcinoma: immunohistochemical detection of TSH-R.

机译:甲状腺乳头状癌预后评分与促甲状腺激素受体(TSH-R)的关系:TSH-R的免疫组化检测。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We have demonstrated the expression of thyrotropin receptor (TSH-R) in thyroid neoplasms (13 adenomas, 21 papillary carcinomas, two follicular carcinomas) and adjacent normal thyroid using the monoclonal antibody against human TSH-R and have also demonstrated a relationship between prognostic scores and the expression of TSH-R. Among the adenomas, eight showed an intensity similar to that of normal thyroid and five showed a higher intensity than normal. Two tumours exhibited heterogeneous distribution of TSH-R. Among the papillary carcinomas, seven showed similar intensity to normal tissue and four showed higher intensity and ten showed weaker intensity. Eight tumours showed heterogeneous distribution of the stain. Among the follicular carcinomas, one showed similar intensity to normal tissue and the other exhibited weaker intensity. Both cases showed homogeneous distribution of TSH-R. The adenomas never showed a weaker intensity than normal thyroid, but various intensities of TSH-R occurred in differentiated carcinomas. There was no significant relationship between the clinical data and the signal intensity in the adenomas. Among the papillary carcinomas, however, the group with weaker intensity had significantly poorer prognostic scores than the other two groups. Thus, we assume that low TSH-R may be expressed by the clinically high-risk group of patients with papillary thyroid carcinoma.
机译:我们已经使用针对人类TSH-R的单克隆抗体证明了促甲状腺激素受体(TSH-R)在甲状腺肿瘤(13腺瘤,21乳头状癌,两个滤泡癌)和邻近的正常甲状腺中的表达,并且还表明了预后评分之间的关​​系和TSH-R的表达。在腺瘤中,有八个显示出与正常甲状腺相似的强度,五个显示出比正常甲状腺更高的强度。两种肿瘤表现出TSH-R的异质分布。在乳头状癌中,有七个显示出与正常组织相似的强度,四个显示出较高的强度,而十个显示出较弱的强度。八个肿瘤显示了染色的异质分布。在滤泡癌中,一种显示出与正常组织相似的强度,另一种显示出较弱的强度。两种情况均显示TSH-R均匀分布。腺瘤从未显示出比正常甲状腺更弱的强度,但是在分化的癌中出现了各种强度的TSH-R。腺瘤的临床数据与信号强度之间无显着关系。然而,在乳头状癌中,强度较弱的组的预后评分显着低于其他两组。因此,我们假设低TSH-R可能由甲状腺乳头状癌的临床高风险组表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号